Golimumab Trough Levels in Patients With Ulcerative Colitis (GLMLEVEL)
Association of Golimumab Trough Levels With Endoscopic and Histologic Healing in Patients With Ulcerative Colitis
Sponsor: Complejo Hospitalario de Navarra
This observational or N/A phase trial investigates Ulcerative Colitis and is currently completed. Complejo Hospitalario de Navarra leads this study, which shows 13 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
-
May 2022 — Jun 2022 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 8 earlier versions
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2019 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Complejo Hospitalario de Navarra
- Gregorio Marañón Hospital
- Hospital Clínico Universitario de Valencia
- Hospital Infanta Sofia
- Hospital San Carlos, Madrid
- Hospital Universitario 12 de Octubre
- Hospital Universitario Fundación Alcorcón
- Hospital Universitario La Fe
- Hospital Universitario La Paz
- Hospital Universitario Ramon y Cajal
- Hospital Universitario de Fuenlabrada
- Merck Sharp & Dohme LLC
- Puerta de Hierro University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .